Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Outcomes after RIC and Abatacept-Based Acute and Chronic Gvhd Prophylaxis in Allogeneic Transplantation for Sickle Cell Disease - Can Calcineurin Inhibitor Use be Curtailed?

Niketa C. Shah, Alexander I. Ngwube, David A Jacobsohn, Shalini Shenoy

Blood (2023) 142 (Supplement 1): 2185.

https://doi.org/10.1182/blood-2023-190524

Published: 2023

Journal Articles

High Exposure of Rabbit Anti-Thymocyte Globulin (ATG) Is Strongly Associated with Inferior DFS in Pediatric Patients with Malignancy Undergoing Alpha-Beta T-Cell Depleted Haploidentical HCT

Christopher C Dvorak, Lucia Holbrook-Brown, Janel R. Long-Boyle, Hisham Abdel-Azim, Anant Vatsayan, Julie-An Talano, Nancy Bunin, Eric Jon Anderson, Allyson Flower, Nahal Lalefar, Christine S Higham, Neena Kapoor, Maryanne Odinakachukwu, David A Jacobsohn, Michael A. Pulsipher

Blood (2023) 142 (Supplement 1): 3533.

https://doi.org/10.1182/blood-2023-178925

Published: 2023

Journal Articles

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Blood (2022) 139 (2): 287–299.

https://doi.org/10.1182/blood.2021013244

Published: 2022

Includes: Supplemental data

Journal Articles

Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups

Courtney M. Rowan, Francis Pike, Kenneth R. Cooke, Robert Krance, Paul A. Carpenter, Christine Duncan, David A. Jacobsohn, Catherine M. Bollard, Conrad Russell Y. Cruz, Abhijeet Malatpure, Sherif S. Farag, Jamie Renbarger, Hao Liu, Giorgos Bakoyannis, Samir Hanash, Sophie Paczesny

Blood (2020) 135 (17): 1428–1437.

https://doi.org/10.1182/blood.2019002334

Published: 2020

Includes: Supplemental data

Journal Articles

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Blood (2020) 135 (15): 1287–1298.

https://doi.org/10.1182/blood.2019003186

Published: 2020

Includes: Supplemental data

Journal Articles

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Blood (2019) 134 (3): 304–316.

https://doi.org/10.1182/blood.2019000216

Published: 2019

Includes: Supplemental data

Journal Articles

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

Monica S. Thakar, Larisa Broglie, Brent Logan, Andrew Artz, Nancy Bunin, Lauri M. Burroughs, Caitrin Fretham, David A. Jacobsohn, Alison W. Loren, Joanne Kurtzberg, Caridad A. Martinez, Shin Mineishi, Adam S. Nelson, Ann Woolfrey, Marcelo C. Pasquini, Mohamed L. Sorror

Blood (2019) 133 (7): 754–762.

https://doi.org/10.1182/blood-2018-09-876284

Published: 2019

Includes: Supplemental data

Journal Articles

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)

Reem Elkeky, MBBS, David A. Jacobsohn, MD, Rajni Agarwal, MD, Swati Naik, MBBS, Neena Kapoor, MD, Lakshmanan Krishnamurti, MD, Mary Slatter, MD, Federica Galaverna, MD, Pietro Merli, MD, Melissa Aldinger, PharmD, Franco Locatelli

Blood (2018) 132 (Supplement 1): 2207.

https://doi.org/10.1182/blood-2018-99-119792

Published: 2018

Journal Articles

Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias

Franco Locatelli, Annalisa Ruggeri, MD PhD, Pietro Merli, MD, Swati Naik, MBBS, Rajni Agarwal, MD, Victor Aquino, MD, David A. Jacobsohn, MD, Waseem Qasim, MD PhD, Eneida R. Nemecek, MD, Lakshmanan Krishnamurti, MD, Deepa Manwani, MD, Melissa Kuhn, PharmD, Neena Kapoor

Blood (2018) 132 (Supplement 1): 307.

https://doi.org/10.1182/blood-2018-99-119481

Published: 2018

Journal Articles

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

Blood (2017) 130 (Supplement 1): 212.

https://doi.org/10.1182/blood.V130.Suppl_1.212.212

Published: 2017

Journal Articles

Predicting chronic GVHD outcomes: are we there yet?

David A. Jacobsohn

Blood (2016) 127 (1): 14–15.

https://doi.org/10.1182/blood-2015-11-681072

Published: 2016

Journal Articles

FFS: an end(point) to our problems in chronic GVHD trials?

David A. Jacobsohn

Blood (2014) 124 (8): 1216–1217.

https://doi.org/10.1182/blood-2014-06-579672

Published: 2014

Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Blood (2013) 122 (21): 706.

https://doi.org/10.1182/blood.V122.21.706.706

Published: 2013

Journal Articles

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium

David A. Jacobsohn, Brenda F. Kurland, Joseph Pidala, Yoshihiro Inamoto, Xiaoyu Chai, Jeanne M. Palmer, Sally Arai, Mukta Arora, Madan Jagasia, Corey Cutler, Daniel Weisdorf, Paul J. Martin, Steven Z. Pavletic, Georgia Vogelsang, Stephanie J. Lee, Mary E. D. Flowers

Blood (2012) 120 (13): 2545–2552.

https://doi.org/10.1182/blood-2012-04-424135

Published: 2012

Includes: Supplemental data

Journal Articles

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

Blood (2011) 118 (16): 4472–4479.

https://doi.org/10.1182/blood-2011-04-349068

Published: 2011

Journal Articles

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis

Blood (2011) 117 (24): 6714–6720.

https://doi.org/10.1182/blood-2010-12-323824

Published: 2011

Journal Articles

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis

Blood (2010) 116 (21): 898.

https://doi.org/10.1182/blood.V116.21.898.898

Published: 2010

Journal Articles

Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease

Blood (2010) 116 (21): 211.

https://doi.org/10.1182/blood.V116.21.211.211

Published: 2010

Journal Articles

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study

David A. Jacobsohn, Andrew L. Gilman, Alfred Rademaker, Brittan Browning, Michael Grimley, Leslie Lehmann, Eneida R. Nemecek, Kimberly Thormann, Kirk R. Schultz, Georgia B. Vogelsang

Blood (2009) 114 (20): 4354–4360.

https://doi.org/10.1182/blood-2009-05-224840

Published: 2009

Includes: Supplemental data

Journal Articles

Shedding some LIGHT on chronic GVHD

David A. Jacobsohn

Blood (2008) 112 (7): 2593–2594.

https://doi.org/10.1182/blood-2008-07-171256

Published: 2008

NARROW

Outcomes after RIC and Abatacept-Based Acute and Chronic Gvhd Prophylaxis in Allogeneic Transplantation for Sickle Cell Disease - Can Calcineurin Inhibitor Use be Curtailed?

High Exposure of Rabbit Anti-Thymocyte Globulin (ATG) Is Strongly Associated with Inferior DFS in Pediatric Patients with Malignancy Undergoing Alpha-Beta T-Cell Depleted Haploidentical HCT

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)

Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

Predicting chronic GVHD outcomes: are we there yet?

FFS: an end(point) to our problems in chronic GVHD trials?

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis

Risk Factors for Major Transplant Related Outcomes In Pediatric Patients with Chronic Graft-Versus-Host Disease

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study

Shedding some LIGHT on chronic GVHD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only